Assignee
HESS GEORG
DE·9 granted patents·28 pending applications·9 citations·filing 2005–2012
Top patents by PatentIndex Score
37 records- 0183US8486706B2L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapyHESS GEORG·Filed 2010·Granted Jul 16, 2013·5 cites·10 claims
- 0272US8501155B2Biochemical markers for acute pulmonary embolismHESS GEORG·Filed 2009·Granted Aug 6, 2013·2 cites·11 claims
- 0367US8771961B2Monitoring myocardial infarction and its treatmentHESS GEORG·Filed 2010·Granted Jul 8, 2014·1 cites·19 claims
- 0464US8062857B1H-FABP as early predictor of myocardial infarctionHESS GEORG·Filed 2009·Granted Nov 22, 2011·1 cites·13 claims
- 0562US8497095B2Biochemical markers for acute pulmonary embolismHESS GEORG·Filed 2009·Granted Jul 30, 2013·0 cites·5 claims
- 0654US9638700B2NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic eventsHESS GEORG·Filed 2012·Granted May 2, 2017·0 cites·3 claims
- 0752US2011229907A1Use of cardiac hormones to assess risk of cardiovascular complication from volume overloadHESS GEORG·Filed 2011·Application pending·0 cites
- 0852US2010167331A1Assessing risk of cardiac intervention in patients suffering from stable coronary heart disease based on gdf-15HESS GEORG·Filed 2009·Application pending·0 cites
- 0951US2010086946A1Plgf, flt1 and endoglin for diagnosing angiogenic status in coronary artery diseaseHESS GEORG·Filed 2009·Application pending·0 cites
- 1050US2006019315A1Multimarker panel for diabetes type 1 and 2HESS GEORG·Filed 2005·Application pending·0 cites
- 1149US2005239138A1Use of cardiac hormones to assess risk of cardiovascular complication from volume overloadHESS GEORG·Filed 2005·Application pending·0 cites
- 1247US8663941B2Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarctionHESS GEORG·Filed 2012·Granted Mar 4, 2014·0 cites·14 claims
- 1347US2008171354A1Natriuretic peptide ratio for diagnosing cardiac dysfunctionsHESS GEORG·Filed 2007·Application pending·0 cites
- 1447US2009081702A1Discriminaton of cardiac dysfunction in pregnant femalesHESS GEORG·Filed 2007·Application pending·0 cites
- 1545US9983213B2Identification of subjects being susceptible to anti-angiogenesis therapyHESS GEORG·Filed 2011·Granted May 29, 2018·0 cites·12 claims
- 1645US8440463B2Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1HESS GEORG·Filed 2010·Granted May 14, 2013·0 cites·13 claims
- 1743US2012164669A1Marker panel for left ventricular hypertrophyHESS GEORG·Filed 2012·Application pending·0 cites
- 1842US2011257022A1Method for assessment of severity of liver cirrhosisHESS GEORG·Filed 2011·Application pending·0 cites
- 1942US2012009607A1Differentiating cardiac- and diabetes mellitus-based causes of kidney damageHESS GEORG·Filed 2011·Application pending·0 cites
- 2042US2011263443A1Differentiating between fibrosis and cirrhosisHESS GEORG·Filed 2011·Application pending·0 cites
- 2142US2012028292A1Methods for diagnosing kidney damage associated with heart failureHESS GEORG·Filed 2011·Application pending·0 cites
- 2241US2011082349A1Means and methods for determining the arteriosclerotic stenosis using inflammatory biomarkersHESS GEORG·Filed 2010·Application pending·0 cites
- 2341US2011072892A1H-fabp as a marker for myocardial hibernationHESS GEORG·Filed 2010·Application pending·0 cites
- 2441US2011107821A1Multimarker panel for monitoring patients with and without overt heart failureHESS GEORG·Filed 2011·Application pending·0 cites
- 2541US2011207629A1Predicting cardiovascular events and renal failure in type 1 diabeticsHESS GEORG·Filed 2011·Application pending·0 cites
- 2641US2011113865A1Using cardiac troponin for monitoring anti-angiogenesis therapyHESS GEORG·Filed 2011·Application pending·0 cites
- 2741US2011081725A1Assessment of complications of patients with type 1 diabetesHESS GEORG·Filed 2010·Application pending·0 cites
- 2840US2011111527A1Multimarker panel for differentiation of dilated cardiomyopathy and as a basis for differential therapyHESS GEORG·Filed 2010·Application pending·0 cites
- 2940US2011059540A1Identifying susceptibility of a subject to cardiac therapy based on determination of a cardiac troponin, scd40l, and c-reactive proteinHESS GEORG·Filed 2010·Application pending·0 cites
- 3040US2011033941A1Risk analysis in patients with and without metabolic syndromeHESS GEORG·Filed 2010·Application pending·0 cites
- 3140US2010273268A1Determining atherosclerotic load using placental growth factorHESS GEORG·Filed 2010·Application pending·0 cites
- 3240US2011053191A1Method for risk reduction in glycemic controlHESS GEORG·Filed 2010·Application pending·0 cites
- 3339US2011081671A1Vascular markers in the remodeling of cardiac injuryHESS GEORG·Filed 2010·Application pending·0 cites
- 3439US2010248288A1Differentiation of causes of right heart failureHESS GEORG·Filed 2010·Application pending·0 cites
- 3539US2010248377A1Detection of contrast medium-induced nephrotoxicityHESS GEORG·Filed 2010·Application pending·0 cites
- 3637US2011159600A1Natriuretic peptides and adiponectin in subjects with a metabolic syndromeHESS GEORG·Filed 2011·Application pending·0 cites
- 3736US2011033886A1Gdf-15 as biomarker in type 1 diabetesHESS GEORG·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →